Keyvisual: Hummingbird hovering in front of a flower
Power, Precision & Agility

Where to find us

Visual Element

About UCB Ventures

  1. UCB Ventures is a €150 million strategic corporate venture fund established in 2017 to further strengthen UCB's ability to create value from novel insights and technologies that can transform the lives of patients suffering from severe diseases.
  2. We invest in innovative therapeutics and technology platforms that are early stage and higher risk, in areas adjacent to or even beyond UCB's therapeutic focus on neurology/neurodegenerative diseases, immunology and muscular skeletal/bone health.
  3. Our team initially made four fund-to-fund investments in selected Healthcare Venture Funds in 2017, and is now focused on long term, direct investments in the US and Europe. Our first direct investment is in StrideBio, a US-based gene therapy company, with several more investments to come in the near future.